Business
XPC: Q3 2024 saw lower sales, improved losses, and a regulatory delay for XP Chemistries
XPC: Q3 2024 saw lower sales, improved losses, and a regulatory delay for XP Chemistries
About this update from Xp Chemistries Ab
XP Chemistries reported lower sales and losses for Q3 2024 but improved operating results year-over-year. Regulatory approval for its capsaicin feed additive is delayed to early 2025, with new financing secured through warrant exercises.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.